Deals
Galectin Therapeutics Raises $10M at 14% Discount via Roth Capital Partners
|
Galectin Therapeutics (NASDAQ CM:GALT) announced that it has raised $9,809,514 in a Registered Direct transaction.
Growth Capitalist (https://growthcapitalist.com/author/aislaks/page/87/)
Galectin Therapeutics (NASDAQ CM:GALT) announced that it has raised $9,809,514 in a Registered Direct transaction.
LabStyle Innovations Corporation (OTC:DRIO) announced that it has raised $2,294,480 in a Units (Common Stock + Warrants) transaction.
Viveve Medical (OTC:VIVMF) announced that it has raised $6,000,000 in a Common Stock transaction.
StoneMor Partners L.P. (NYSE:STON) announced that it has secured up to $100,000,000 in an ATM (At the Market) transaction.